A variety of methods are currently employed qualitatively looking for the presence or absence of Coronary Artery Disease (CAD). These tests are limited by that, which they are looking for. In the instance of Coronary Artery Calcium (CAC) scoring, CAC scores are looking for the presence or absence of calcium. Not all atherosclerotic CAD has sclerotic lesions. Consequently, a zero or low CAC value does not exclude CAD. This paper represents the importance of clinical decision making when CAC scoring fails to fi nd CAD.
Introduction
One of the fi rst lessons you are taught during clinical rotations in medical school is that a negative test doesn't necessarily help you. It either means what you are looking for isn't there, or the test missed it. The underlying message is that a test, which has acceptable sensitivity-positive if there is a problem-may have less than desirable specifi city (exclusion of the problem), when the test result returns negative. Thus, if the test doesn't fi nd the problem, you and the patient are left with the question of what to do next.
A currently promulgated anatomic test for Coronary Artery Disease (CAD) is the Coronary Artery Calcium (CAC) Computed Tomography (CT) test, based upon the presumption that all CAD eventually demonstrates calcium deposition [1] [2] [3] [4] [5] . The CAC test, which is scored based upon the detection of calciumusing essentially the same approach as the bone density exam (aka DEXA) -is derived from a semi-quantitative value called the Agatston score.
The Agatston score is a weighted value of 1, 2, 3 or 4 ( Table  1 ) based upon the radio density of the tissue measured in Hounsfi eld units (Hu). This weighted value is then multiplied by the area (mm 2 ) based upon the limits of the CT device used to derive the Agatston score.
One proposed use of the CAC score is its inclusion into a battery of tests already being used for treatment decisionmaking [6, 7] . We present a clinical example of one such patient seeking further treatment recommendations following CAC testing, after modifying treatment for elevated total cholesterol levels.
Clinical Case
Following routine blood work revealing a total cholesterol level of 146mg/dl (3.77mmol/l), a 56-year-old Caucasian male elected to modify his dietary habits in an effort to lower his blood cholesterol. Six months later he developed chest discomfort. His repeat total cholesterol revealed a value of 230mg/dl (5.95mmol/l). His physician referred him for a CAC heart scan, shown in Figure 1 , to determine his risk for CAD and help determine if further treatment was indicated.
The CAC study revealed a calcium score of zero. This placed the patient in the <5%, very low risk group for CAD with no identifi able plaque [1-3,6-7] and a low but not zero probability of him having a greater than 50% diameter coronary artery narrowing [8] . After further discussions with the patient, a coronary arteriogram was scheduled. This revealed a 99% proximal narrowing of his Left Anterior Descending (LAD) artery, which was subsequently treated with stent placement as shown in Figure 2 .
Discussion
The presence of a negative diagnostic test does not automatically exclude a problem any more than a positive 
